share_log

Exact Sciences Maintains Full-year 2024 Revenue Guidance Of $2.81B - $2.85B, Est $2.829B

Benzinga ·  16:27
  • Raises full-year adjusted EBITDA guidance midpoint by $8M.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment